跳至主要内容
临床试验/ITMCTR2024000103
ITMCTR2024000103尚未招募2 期

A retrospective cohort study based on multi-center and propensity score matching was used to evaluate the effect of Tanreqing Injection on Influence of survival prognosis in patients with severe COVID-19 infection

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
11 至 90(—)
性别
All

入选标准

  • (1) Conform to the criteria for moderate and severe diagnosis of the novel coronavirus infection Diagnosis and Treatment Protocol (Trial Version 9 and 10); Diagnostic criteria for patients with viral pneumonia in (Trial Version 9 and 10);
  • (2)Age range from 18 to 75 years old (including 18 and 75 years old), gender is not limited.

排除标准

  • Exclude patients who experience the endpoint death event within 48 hours of hospital admission.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

相似试验

A retrospective cohort study based on multi-center... | 临床试验